位置:首页 > 蛋白库 > E41LB_HUMAN
E41LB_HUMAN
ID   E41LB_HUMAN             Reviewed;         900 AA.
AC   Q9H329; Q5T4G5; Q5T4G6; Q9H328; Q9P2V3;
DT   23-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   14-OCT-2008, sequence version 2.
DT   03-AUG-2022, entry version 162.
DE   RecName: Full=Band 4.1-like protein 4B;
DE   AltName: Full=Erythrocyte membrane protein band 4.1-like 4B {ECO:0000312|HGNC:HGNC:19818};
DE   AltName: Full=FERM-containing protein CG1;
DE   AltName: Full=Protein EHM2;
GN   Name=EPB41L4B {ECO:0000312|HGNC:HGNC:19818};
GN   Synonyms=EHM2 {ECO:0000312|HGNC:HGNC:19818},
GN   LULU2 {ECO:0000303|PubMed:22006950};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANT THR-816.
RX   PubMed=10603000; DOI=10.1007/s003350010017;
RA   Chadwick B.P., Leyne M., Gill S., Liebert C.B., Mull J., Mezey E.,
RA   Robbins C.M., Pinkett H.W., Makalowska I., Maayan C., Blumenfeld A.,
RA   Axelrod F.B., Brownstein M., Gusella J.F., Slaugenhaupt S.A.;
RT   "Cloning, mapping, and expression of a novel brain-specific transcript in
RT   the familial dysautonomia candidate region on chromosome 9q31.";
RL   Mamm. Genome 11:81-83(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=10783258; DOI=10.1006/geno.2000.6154;
RA   Shimizu K., Nagamachi Y., Tani M., Kimura K., Shiroishi T., Wakana S.,
RA   Yokota J.;
RT   "Molecular cloning of a novel NF2/ERM/4.1 superfamily gene, Ehm2, that is
RT   expressed in high-metastatic K1735 murine melanoma cells.";
RL   Genomics 65:113-120(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=14521927; DOI=10.1016/j.bbrc.2003.08.147;
RA   Chauhan S., Pandey R., Way J.F., Sroka T.C., Demetriou M.C., Kunz S.,
RA   Cress A.E., Mount D.W., Miesfeld R.L.;
RT   "Androgen regulation of the human FERM domain encoding gene EHM2 in a cell
RT   model of steroid-induced differentiation.";
RL   Biochem. Biophys. Res. Commun. 310:421-432(2003).
RN   [5]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22006950; DOI=10.1083/jcb.201104118;
RA   Nakajima H., Tanoue T.;
RT   "Lulu2 regulates the circumferential actomyosin tensile system in
RT   epithelial cells through p114RhoGEF.";
RL   J. Cell Biol. 195:245-261(2011).
RN   [6]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=23664528; DOI=10.1016/j.jdermsci.2013.04.008;
RA   Bosanquet D.C., Ye L., Harding K.G., Jiang W.G.;
RT   "Expressed in high metastatic cells (Ehm2) is a positive regulator of
RT   keratinocyte adhesion and motility: The implication for wound healing.";
RL   J. Dermatol. Sci. 71:115-121(2013).
CC   -!- FUNCTION: Up-regulates the activity of the Rho guanine nucleotide
CC       exchange factor ARHGEF18 (By similarity). Involved in the regulation of
CC       the circumferential actomyosin belt in epithelial cells
CC       (PubMed:22006950). Promotes cellular adhesion, migration and motility
CC       in vitro and may play a role in wound healing (PubMed:23664528). May
CC       have a role in mediating cytoskeletal changes associated with steroid-
CC       induced cell differentiation (PubMed:14521927).
CC       {ECO:0000250|UniProtKB:Q9JMC8, ECO:0000269|PubMed:14521927,
CC       ECO:0000269|PubMed:22006950, ECO:0000269|PubMed:23664528}.
CC   -!- SUBUNIT: Interacts (via FERM domain) with ARHGEF18 (via C-terminus);
CC       the interaction activates ARHGEF18. {ECO:0000250|UniProtKB:Q9JMC8}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:22006950}. Cell
CC       junction, tight junction {ECO:0000269|PubMed:22006950}.
CC       Note=Accumulates along apical cell-cell boundaries and is also detected
CC       in the cytoplasm in a punctate manner. {ECO:0000269|PubMed:22006950}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H329-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H329-2; Sequence=VSP_007202, VSP_007203;
CC   -!- TISSUE SPECIFICITY: Expressed at higher levels in acute wounds than
CC       chronic wounds with increased expression in healing wounds, especially
CC       at the leading wound edge (PubMed:23664528). Isoform 1 is highly
CC       expressed in brain. Isoform 2 is highly expressed in testis with lower
CC       levels in prostate and breast (PubMed:14521927).
CC       {ECO:0000269|PubMed:14521927, ECO:0000269|PubMed:23664528}.
CC   -!- INDUCTION: By the androgen dihydrotestosterone (DHT).
CC       {ECO:0000269|PubMed:14521927}.
CC   -!- PTM: May be negatively regulated by phosphorylation.
CC       {ECO:0000250|UniProtKB:Q9JMC8}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG43366.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAG43368.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF153416; AAG43366.1; ALT_FRAME; mRNA.
DR   EMBL; AF153418; AAG43368.1; ALT_FRAME; mRNA.
DR   EMBL; AB032179; BAA96079.2; -; mRNA.
DR   EMBL; AL359963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL358815; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS43859.1; -. [Q9H329-1]
DR   CCDS; CCDS43860.1; -. [Q9H329-2]
DR   RefSeq; NP_060894.2; NM_018424.3. [Q9H329-2]
DR   RefSeq; NP_061987.3; NM_019114.4. [Q9H329-1]
DR   AlphaFoldDB; Q9H329; -.
DR   SMR; Q9H329; -.
DR   BioGRID; 120044; 100.
DR   IntAct; Q9H329; 18.
DR   MINT; Q9H329; -.
DR   STRING; 9606.ENSP00000363694; -.
DR   iPTMnet; Q9H329; -.
DR   PhosphoSitePlus; Q9H329; -.
DR   BioMuta; EPB41L4B; -.
DR   DMDM; 209572611; -.
DR   EPD; Q9H329; -.
DR   jPOST; Q9H329; -.
DR   MassIVE; Q9H329; -.
DR   MaxQB; Q9H329; -.
DR   PaxDb; Q9H329; -.
DR   PeptideAtlas; Q9H329; -.
DR   PRIDE; Q9H329; -.
DR   ProteomicsDB; 80657; -. [Q9H329-1]
DR   ProteomicsDB; 80658; -. [Q9H329-2]
DR   Antibodypedia; 29426; 81 antibodies from 22 providers.
DR   DNASU; 54566; -.
DR   Ensembl; ENST00000374557.4; ENSP00000363685.3; ENSG00000095203.15. [Q9H329-2]
DR   Ensembl; ENST00000374566.8; ENSP00000363694.3; ENSG00000095203.15. [Q9H329-1]
DR   GeneID; 54566; -.
DR   KEGG; hsa:54566; -.
DR   MANE-Select; ENST00000374566.8; ENSP00000363694.3; NM_019114.5; NP_061987.3.
DR   UCSC; uc004bdz.3; human. [Q9H329-1]
DR   CTD; 54566; -.
DR   DisGeNET; 54566; -.
DR   GeneCards; EPB41L4B; -.
DR   HGNC; HGNC:19818; EPB41L4B.
DR   HPA; ENSG00000095203; Tissue enhanced (liver, pancreas).
DR   MIM; 610340; gene.
DR   neXtProt; NX_Q9H329; -.
DR   OpenTargets; ENSG00000095203; -.
DR   PharmGKB; PA134986250; -.
DR   VEuPathDB; HostDB:ENSG00000095203; -.
DR   eggNOG; KOG3530; Eukaryota.
DR   GeneTree; ENSGT00940000158331; -.
DR   HOGENOM; CLU_003623_5_0_1; -.
DR   InParanoid; Q9H329; -.
DR   OMA; IYTPEAC; -.
DR   OrthoDB; 241659at2759; -.
DR   PhylomeDB; Q9H329; -.
DR   TreeFam; TF319780; -.
DR   PathwayCommons; Q9H329; -.
DR   SignaLink; Q9H329; -.
DR   SIGNOR; Q9H329; -.
DR   BioGRID-ORCS; 54566; 5 hits in 1069 CRISPR screens.
DR   ChiTaRS; EPB41L4B; human.
DR   GenomeRNAi; 54566; -.
DR   Pharos; Q9H329; Tbio.
DR   PRO; PR:Q9H329; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q9H329; protein.
DR   Bgee; ENSG00000095203; Expressed in secondary oocyte and 166 other tissues.
DR   Genevisible; Q9H329; HS.
DR   GO; GO:0045177; C:apical part of cell; IDA:MGI.
DR   GO; GO:0005923; C:bicellular tight junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IEA:InterPro.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc.
DR   GO; GO:0031032; P:actomyosin structure organization; IDA:MGI.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IMP:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   GO; GO:0051549; P:positive regulation of keratinocyte migration; IMP:UniProtKB.
DR   GO; GO:0042060; P:wound healing; IDA:UniProtKB.
DR   CDD; cd14473; FERM_B-lobe; 1.
DR   Gene3D; 1.20.80.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR030698; Band4.1-like4B.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR000798; Ez/rad/moesin-like.
DR   InterPro; IPR014847; FERM-adjacent.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_sf.
DR   InterPro; IPR035963; FERM_2.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR019747; FERM_CS.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR018979; FERM_N.
DR   InterPro; IPR018980; FERM_PH-like_C.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   PANTHER; PTHR23280:SF18; PTHR23280:SF18; 1.
DR   Pfam; PF08736; FA; 1.
DR   Pfam; PF09380; FERM_C; 1.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF09379; FERM_N; 1.
DR   PRINTS; PR00935; BAND41.
DR   PRINTS; PR00661; ERMFAMILY.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM01195; FA; 1.
DR   SMART; SM01196; FERM_C; 1.
DR   SUPFAM; SSF47031; SSF47031; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS00661; FERM_2; 1.
DR   PROSITE; PS50057; FERM_3; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell junction; Cytoplasm; Phosphoprotein;
KW   Reference proteome; Tight junction.
FT   CHAIN           1..900
FT                   /note="Band 4.1-like protein 4B"
FT                   /id="PRO_0000219404"
FT   DOMAIN          85..369
FT                   /note="FERM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00084"
FT   REGION          23..48
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          400..425
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          492..519
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          528..547
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          706..750
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        706..730
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         470..518
FT                   /note="SYPLPSPVLSSSDRLPFGIEENGGTPFLTAASGRHHHQHQHQHQHQHHS ->
FT                   RPSFQDDRSHWKASASGDDSHFDYVHDQNQKNLGGMQSMMYRDKLMTAL (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10603000,
FT                   ECO:0000303|PubMed:10783258"
FT                   /id="VSP_007202"
FT   VAR_SEQ         519..900
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10603000,
FT                   ECO:0000303|PubMed:10783258"
FT                   /id="VSP_007203"
FT   VARIANT         816
FT                   /note="N -> T (in dbSNP:rs3750450)"
FT                   /evidence="ECO:0000269|PubMed:10603000"
FT                   /id="VAR_048356"
FT   CONFLICT        73
FT                   /note="V -> M (in Ref. 2; BAA96079)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        899
FT                   /note="E -> R (in Ref. 1; AAG43366)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   900 AA;  99712 MW;  9A4BD658DBE65BDE CRC64;
     MLRFLRRTFG RRSMQRYARG AAGRGAAGLG DERDGGPRGG PAAAASSSAL PAAPGGSVFP
     AGGGPLLTGG AAVHISAAGA AKATLYCRVF LLDGTEVSVD LPKHAKGQDL FDQIVYHLDL
     VETDYFGLQF LDSAQVAHWL DHAKPIKKQM KIGPAYALHF RVKYYSSEPN NLREEFTRYL
     FVLQLRHDIL SGKLKCPYET AVELAALCLQ AELGECELPE HTPELVSEFR FIPNQTEAME
     FDIFQRWKEC RGKSPAQAEL SYLNKAKWLE MYGVDMHVVR GRDGCEYSLG LTPTGILIFE
     GANKIGLFFW PKITKMDFKK SKLTLVVVED DDQGREQEHT FVFRLDSART CKHLWKCAVE
     HHAFFRLRTP GNSKSNRSDF IRLGSRFRFS GRTEYQATHG SRLRRTSTFE RKPSKRYPSR
     RHSTFKASNP VIAAQLCSKT NPEVHNYQPQ YHPNIHPSQP RWHPHSPNVS YPLPSPVLSS
     SDRLPFGIEE NGGTPFLTAA SGRHHHQHQH QHQHQHHSNY SLSLTLENKE GPLRSPNSSS
     KSLTKLSPGT PALFSEAAAH LKKLELETVK AAGPWPPLHI NINKAEEKKV SEKTLQTPLL
     PSPVADHVKC NILKAQLENA SRVNIQGGKE ESPFVNINKK SSLQDASVRS PIPIRVETAQ
     PAVEKPEIKP PRVRKLTRQY SFDEDDLPPD LAEAVGVTTS TTTNTTTAAT QVSVPLPSPK
     VQNVSSPHKS EGKGLLSPGA KSPSDRGGAF TLEPGDLLMD FTEATPLAEP ASNPHCAHSR
     CSPPLSLPMK EETTGVCMYP PIKTRLIKTF PVDTMNPFPD TFTTGPQFTA DFRDSKLQCC
     PGPTSPLIPA ATLRPLTETV STVQTIYTTR KPVSLAASAE TLRQELEREK MMKRLLMTEL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024